423 related articles for article (PubMed ID: 17440491)
1. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
[TBL] [Abstract][Full Text] [Related]
4. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
Dorrance AM; Rupp N; Pollock DM; Newman JW; Hammock BD; Imig JD
J Cardiovasc Pharmacol; 2005 Dec; 46(6):842-8. PubMed ID: 16306811
[TBL] [Abstract][Full Text] [Related]
5. Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex.
Wu HF; Yen HJ; Huang CC; Lee YC; Wu SZ; Lee TS; Lin HC
J Biomed Sci; 2015 Oct; 22():94. PubMed ID: 26494028
[TBL] [Abstract][Full Text] [Related]
6. Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation.
Chang LH; Lin HC; Huang SS; Chen IC; Chu KW; Chih CL; Liang YW; Lee YC; Chen YY; Lee YH; Lee IH
Sci Rep; 2018 Jan; 8(1):118. PubMed ID: 29311641
[TBL] [Abstract][Full Text] [Related]
7. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase: a new target for cardioprotection.
Gross GJ; Nithipatikom K
Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
[TBL] [Abstract][Full Text] [Related]
10. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
Shaik JS; Ahmad M; Li W; Rose ME; Foley LM; Hitchens TK; Graham SH; Hwang SH; Hammock BD; Poloyac SM
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1605-13. PubMed ID: 24043255
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.
Simpkins AN; Rudic RD; Schreihofer DA; Roy S; Manhiani M; Tsai HJ; Hammock BD; Imig JD
Am J Pathol; 2009 Jun; 174(6):2086-95. PubMed ID: 19435785
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
[TBL] [Abstract][Full Text] [Related]
13. Epoxyeicosanoid Signaling Provides Multi-target Protective Effects on Neurovascular Unit in Rats After Focal Ischemia.
Liu Y; Wan Y; Fang Y; Yao E; Xu S; Ning Q; Zhang G; Wang W; Huang X; Xie M
J Mol Neurosci; 2016 Feb; 58(2):254-65. PubMed ID: 26545915
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension.
Li J; Carroll MA; Chander PN; Falck JR; Sangras B; Stier CT
Front Biosci; 2008 May; 13():3480-7. PubMed ID: 18508449
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney.
Lee JP; Yang SH; Lee HY; Kim B; Cho JY; Paik JH; Oh YJ; Kim DK; Lim CS; Kim YS
PLoS One; 2012; 7(5):e37075. PubMed ID: 22590647
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of the soluble epoxide hydrolase (sEH) inhibitor AUDA on atherosclerotic diseases.
Zhang J; Liu YS; Lu QH
Pharmazie; 2015 Jan; 70(1):24-8. PubMed ID: 25975094
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke.
Zuloaga KL; Krasnow SM; Zhu X; Zhang W; Jouihan SA; Shangraw RE; Alkayed NJ; Marks DL
PLoS One; 2014; 9(5):e97529. PubMed ID: 24824753
[TBL] [Abstract][Full Text] [Related]
18. Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus.
Jouihan SA; Zuloaga KL; Zhang W; Shangraw RE; Krasnow SM; Marks DL; Alkayed NJ
J Cereb Blood Flow Metab; 2013 Oct; 33(10):1650-6. PubMed ID: 23899929
[TBL] [Abstract][Full Text] [Related]
19. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
Jung O; Brandes RP; Kim IH; Schweda F; Schmidt R; Hammock BD; Busse R; Fleming I
Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457
[TBL] [Abstract][Full Text] [Related]
20. Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts.
Bannehr M; Löhr L; Gelep J; Haverkamp W; Schunck WH; Gollasch M; Wutzler A
Cardiovasc Toxicol; 2019 Aug; 19(4):365-371. PubMed ID: 30725262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
